A synthetic peptide for use as a blocking control in assays to test for specificity of NCAPD2 antibody, Alternative Names: NCAPD2 control peptide, NCAPD2 antibody Blocking Peptide, Anti-NCAPD2 Blocking Peptide, Non-Smc Condensin I Complex Subunit D2 Blocking Peptide, CAP-D2 Blocking Peptide, CNAP1 Blocking Peptide, KIAA0159 Blocking Peptide, hCAP-D2 Blocking Peptide, NCAPD2, NCAPD-2, NCAPD 2, NCAPD-2 Blocking Peptide, NCAPD 2 Blocking Peptide
Aufreinigung
The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen.
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
NCAPD2
(Non-SMC Condensin I Complex, Subunit D2 (NCAPD2))
Hintergrund
NCAPD2 is the regulatory subunit of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condense chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the presence of type II topoisomerases. NCAPD2 may target the condensin complex to DNA via its C-terminal domain.